Abacus Medicine Group Tech Stack

Pharmaceutical distributor and services platform scaling access across Europe

Pharmaceutical Manufacturing København, Hovedstaden 1,001–5,000 employees Founded 2004 Privately Held

Abacus Medicine Group operates a multi-brand pharmaceutical distribution and services business spanning parallel distribution, clinical trial supply, and unlicensed medicines across Europe. The tech stack reveals a mature but traditional enterprise infrastructure (SAP, Dynamics 365, Power BI, Azure) with recent data engineering additions (Databricks, PySpark, SQL, Azure Data Factory), suggesting active investment in supply-chain visibility and financial analytics. Hiring across operations, quality, regulatory, and finance — combined with active projects around portfolio valuation, licensing optimization, and acquisition value realization — indicates the company is in active M&A and portfolio-consolidation mode.

Tech Stack 31 technologies

Core StackSAP Adobe InDesign Adobe Illustrator Dynamics 365 Power BI Trello Salesforce Databricks Python PySpark Azure DevOps Azure Data Factory Power Apps Power Automate Word Excel Dynamics 365 Finance and Operations Photoshop Microsoft Office SharePoint Viva Engage Adobe Acrobat SQL Git Power Pages Azure Storage Azure InDesign Outlook PowerPoint+1 more

What Abacus Medicine Group Is Building

◆Challenges

Monitoring regulatory changes
Value realization from acquisitions
Ensuring gdp compliance
Expanding footprint across europe
Strengthening pharmaceutical organization
Bridging supply gaps
Improving portfolio performance
Balancing regulatory requirements and timelines
Meeting regulatory kpis
Parallel trade speed

▲Active Projects

Parallel distribution marketing authorization function
Continuous improvement of production costing model
Proof reading
Automating portfolio workflows
Valuation models for licensing
High-impact bd&l deals
Rolling forecast process
Licensing efficiency optimization
Change management for licensing activities
Dashboard development for financial kpis

Hiring Activity

Steady60 roles · 20 in 30d

Department

Ops

Legal

Quality

Finance

Regulatory

Sales

Data

Seniority

Mid

Senior

Junior

Intern

Manager

Director

Lead

Notable leadership hires: Go-to-Market Lead, Director, Transactions, Post Merger Integration Lead

Company intelligence

Find more companies like Abacus Medicine Group by tech stack, pain points and active projects

Get started free

About Abacus Medicine Group

Founded in 2004, Abacus Medicine Group operates four brands delivering pharmaceutical access solutions to millions of patients globally, with particular focus on European markets. The company serves healthcare systems and patients through parallel distribution (leveraging price arbitrage across regulated markets), unlicensed medicines (addressing market gaps), clinical trial supply logistics, and pharma services including consulting. With 1,750+ colleagues across multiple European countries and ranked among Denmark's 100 largest companies, the group manages a complex, regulated supply chain while balancing acquisition integration, portfolio optimization, and European expansion. Core operational challenges center on regulatory compliance (GDP, licensing), cross-border distribution speed, and financial modeling for deal valuation and portfolio performance.

HeadquartersKøbenhavn, Hovedstaden

Company Size1,001–5,000 employees

Founded2004

Hiring MarketsHungary, Denmark, Spain, Germany, Belgium, Netherlands, United Kingdom

Frequently Asked Questions

What is Abacus Medicine Group's tech stack?

Enterprise core (SAP, Dynamics 365 Finance and Operations, Salesforce), analytics (Power BI, Databricks, Python, PySpark, SQL), cloud infrastructure (Azure, Azure Data Factory, Azure DevOps, Azure Storage), and Office/collaboration tools (Word, Excel, SharePoint, Viva Engage).

What is Abacus Medicine Group working on?

Portfolio optimization (licensing valuation, acquisition value realization), supply-chain automation (parallel distribution workflows, portfolio dashboards), regulatory compliance initiatives, and rolling forecast and costing model improvements.